276.96MMarket Cap-1.78P/E (TTM)
1.970High1.730Low687.91KVolume1.970Open1.905Pre Close1.25MTurnover0.89%Turnover RatioLossP/E (Static)158.72MShares5.25052wk High2.82P/B135.11MFloat Cap0.39552wk Low--Dividend TTM77.42MShs Float13.780Historical High--Div YieldTTM12.59%Amplitude0.393Historical Low1.816Avg Price1Lot Size
Renovaro Stock Forum
keeping my eyes on this one
RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing
RenovaroCube (NASDAQ: RENB), a leader in AI-driven cancer diagnostics, presented groundbreaking research at the Molecular Analysis for Precision Oncology Congress on October 16, 2024. The study explores the use of Oxford Nanopore sequencing on circulating cell-free DNA (cfDNA) from blood plasma to detect copy number alterations (CNAs) in lung cancer patients.
Key findi...
Globe Newswire 17-Sep-2024 9:00 AM
No comment yet